ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Apr 29, 2022 13:00 JST
Source:
Cnergenz Berhad
CNERGENZ Berhad launches Prospectus for ACE Market IPO
Aims to raise RM58 million from listing
KUALA LUMPUR, Apr 29, 2022 - (ACN Newswire) - Cnergenz Berhad (CNERGENZ), an established electronics manufacturing solutions provider based in Penang, has launched the Company's Prospectus today for its upcoming initial public offering (IPO) on the ACE Market of Bursa Malaysia Securities Berhad (Bursa Securities).
Mr. David Lim, Chief Executive Officer of UOB Kay Hian Securities (M) Sdn Bhd; Mr. Kong Chia Liang, Chief Operating Officer & Executive Director of CNERGENZ Berhad; Dato' Azman bin Mahmud, Independent Non-Executive Chairman of CNERGENZ Berhad; Mr. Lye Yhin Choy, Chief Executive Officer & Executive Director of CNERGENZ Berhad; Mr. Lye Thim Loong, Chief Corporate Officer & Executive Director of CNERGENZ Berhad [L-R]
Applications for the IPO have opened starting at 10.00 a.m. today following the Prospectus launch and will close on 11 May 2022. The targeted IPO listing date of the Company on the ACE Market is on 24 May 2022. At the IPO price of RM0.58 per share, CNERGENZ will have a market capitalisation of RM288.84 million ahead of its debut.
The IPO involves the public issue of 100.0 million issue shares and an offer for sale of 50.0 million offer shares by way of private placement at the IPO price of RM0.58 per share. From the public issue, 25.0 million issue shares will be made available for application to the Malaysian public, 10.0 million shares will be allocated for application by eligible directors and employees as well as persons who have contributed to the success of CNERGENZ Group, 52.75 million shares will be reserved for private placement to identified investors and 12.25 million shares will be reserved for private placement to identified Bumiputera investors approved by the Ministry of International Trade and Industry, Malaysia (MITI).
The IPO is expected to raise gross proceeds of RM58.0 million and shall primarily be channelled towards the Group's expansion of its operational facility, as well as research and development expenditure and working capital purposes.
CNERGENZ is an established electronics manufacturing solutions provider specialising in surface mount technology (SMT) catering to the electronics and semiconductor industries (E&S Industries) in Malaysia, Thailand and Vietnam. The Group has an established track record in providing integrated solutions that suit the evolving nature and changing technological landscape of the E&S Industries since the commencement of its business in 2004.
Chief Executive Officer of CNERGENZ Berhad, Mr. Lye Yhin Choy, said, "We are elated to have reached a new milestone with the Prospectus launch today, bringing us a step closer towards becoming a listed entity on the ACE Market of Bursa Securities. Having been in the E&S space since 2004, our listing is in line with our growth plans and strategies to scale up our operations, expand our integrated solutions and smart factory solutions offerings and develop our own proprietary range of solutions."
Chief Executive Officer of UOB Kay Hian Securities (M) Sdn. Bhd. (UOB Kay Hian), Mr. David Lim said, "We are pleased that the interest among institutional and selected investors, as well as MITI Bumiputera institutional and individual investors have been encouraging with many indicating strong interest to subscribe for the IPO."
UOB Kay Hian is the principal adviser, sponsor, underwriter, and placement agent for CNERGENZ's IPO.
CNERGENZ Bhd:
https://cnergenz.com
CNERGENZ Bhd: [BURSA: CNERGENZ]
Source: Cnergenz Berhad
Sectors: Electronics, Daily Finance, Local Biz, Manufacturing
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
Hong Kong Watch & Clock Fair, Salon de TIME return in September
Aug 30, 2025 02:50 JST
Honda Announces New Plan for Relocation of Global Head Office to Yaesu Area in Tokyo and Reconstruction of Honda Aoyama Building
Aug 29, 2025 18:54 JST
Ministry Of Health, Labour and Welfare Grants Orphan Drug Designation in Japan to Anticancer Agent Tazemetostat for Unresectable INI1-Negative Epithelioid Sarcoma
Aug 29, 2025 18:17 JST
Hitachi Energy acquires remaining stake of eks Energy, reinforcing leadership in power conversion systems for energy storage
Aug 29, 2025 15:17 JST
SenseTime Announces 2025 Interim Results
Aug 28, 2025 21:20 JST
Ausnutria 2025 Interim Results Announcement: Revenue and Profit Maintain Resilient Dual Growth
Aug 28, 2025 19:09 JST
Baguio Green Group (1397.HK) Announces 2025 Interim Results
Aug 28, 2025 19:03 JST
Production, Sales and Export Results for July, 2025
Aug 28, 2025 17:36 JST
Sales, Production, and Export Results for July 2025
Aug 28, 2025 17:25 JST
The University of Tokyo and DENSO Jointly Establish a Social Cooperation Program: "Building Sustainable Production System Infrastructure with Advanced AI Technology"
Aug 28, 2025 16:33 JST
Overview of Honda Exhibits at the Japan Mobility Show 2025
Aug 28, 2025 15:49 JST
NEC develops AI technology for digitalizing work tasks without the need for pre-training and utilizing video from multiple cameras covering wide area worksites
Aug 27, 2025 22:57 JST
Result of the Business Plan Review for the Offshore Wind Power Generation Projects in Japan
Aug 27, 2025 22:27 JST
Fujitsu develops AI agent platform for the healthcare sector to enhance operational efficiency and ensure stable medical service provision
Aug 27, 2025 21:50 JST
MHI Becomes First Japanese Company to Acquire ISO 19443:2018 Certification in the Nuclear Energy Field
Aug 27, 2025 21:32 JST
Mitsubishi Logisnext to Demonstrate Automated Forklift Equipped with "SynfoX" at "4th INNOVATION EXPO"
Aug 27, 2025 20:59 JST
TANAKA to Showcase Advanced Semiconductor Materials in its Inaugural Participation at SEMICON India 2025
Aug 26, 2025 13:30 JST
Honda to Hold Official e-Motorsports Event, "Honda Racing eMS 2025"
Aug 26, 2025 13:17 JST
Mitsubishi Corporation Invests in Fullerton Health
Aug 26, 2025 12:54 JST
Austria and Germany to become the first markets in the European Union (EU) to launch LEQEMBI(R) (lecanemab)
Aug 25, 2025 19:30 JST
More Latest Release >>
Related Release
CNERGENZ Posts RM76.58 Million in Revenue for 2Q FY2022
August 17 2022 18:00 JST
CNERGENZ Berhad Posts RM36.9 Million in Revenue for 1Q FY2022
May 27 2022 21:00 JST
CNERGENZ Berhad Lists on ACE Market, Share Price Gains 4.31% to RM0.605 on Debut
May 25 2022 12:00 JST
CNERGENZ Berhad IPO Shares Oversubscribed by 40.32 Times
May 13 2022 19:00 JST
Electronics Manufacturing Solutions Provider Cnergenz Berhad Enlists UOB Kay Hian Securities as Underwriter for Its Listing Exercise
April 04 2022 16:00 JST
More Press release >>